Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (10): 1012-1014.DOI: 10.3969/j.issn.1673-8640.2021.010.004
Previous Articles Next Articles
Received:2021-03-15
Online:2021-10-30
Published:2021-11-08
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.010.004
| 组别 | 白细胞计数/ （×109/L） | 淋巴细胞百分比/% | 单核细胞百分比/% | 中性粒细胞百分比/% | 嗜酸性粒细胞百分比/% | 嗜碱性粒细胞百分比/% | 红细胞计数/（×1012/L） |
|---|---|---|---|---|---|---|---|
| 阿米巴原虫组 | 8.12±3.70* | 28.04±8.50* | 5.90±1.60 | 60.18±11.70 | 5.07±5.30 | 0.48±0.30 | 4.69±0.80 |
| 人芽囊原虫组 | 5.68±2.20 | 27.99±9.40* | 6.51±1.50* | 59.77±9.20 | 3.85±2.90 | 0.55±0.40 | 4.55±0.70 |
| 其他寄生虫组 | 7.91±3.10 | 24.76±8.90 | 5.91±1.60 | 62.31±10.10 | 5.52±6.40 | 0.43±0.30 | 4.11±0.70 |
| 对照组 | 5.62±1.30 | 33.96±7.10 | 5.29±1.20 | 55.64±7.50 | 2.91±1.50 | 1.43±0.70 | 4.61±0.80 |
| P值 | <0.001 | <0.001 | 0.034 | 0.039 | 0.074 | 0.572 | 0.043 |
| 组别 | 白细胞计数/ （×109/L） | 淋巴细胞百分比/% | 单核细胞百分比/% | 中性粒细胞百分比/% | 嗜酸性粒细胞百分比/% | 嗜碱性粒细胞百分比/% | 红细胞计数/（×1012/L） |
|---|---|---|---|---|---|---|---|
| 阿米巴原虫组 | 8.12±3.70* | 28.04±8.50* | 5.90±1.60 | 60.18±11.70 | 5.07±5.30 | 0.48±0.30 | 4.69±0.80 |
| 人芽囊原虫组 | 5.68±2.20 | 27.99±9.40* | 6.51±1.50* | 59.77±9.20 | 3.85±2.90 | 0.55±0.40 | 4.55±0.70 |
| 其他寄生虫组 | 7.91±3.10 | 24.76±8.90 | 5.91±1.60 | 62.31±10.10 | 5.52±6.40 | 0.43±0.30 | 4.11±0.70 |
| 对照组 | 5.62±1.30 | 33.96±7.10 | 5.29±1.20 | 55.64±7.50 | 2.91±1.50 | 1.43±0.70 | 4.61±0.80 |
| P值 | <0.001 | <0.001 | 0.034 | 0.039 | 0.074 | 0.572 | 0.043 |
| 组别 | 丙氨酸氨基转移酶/（U/L） | 白蛋白/ （g/L） | 天门冬氨酸氨基转移酶/（U/L） | 乳酸脱氢酶/（U/L） | 尿酸/ （μmol/L） | 尿素/（mmol/L） | 肌酐/ （μmol/L） |
|---|---|---|---|---|---|---|---|
| 阿米巴原虫组 | 22.3±10.5 | 42.57±6.10 | 25.38±7.80 | 185.8±61.9 | 344.4±101.8* | 4.89±1.40 | 88.54±28.90 |
| 人芽囊原虫组 | 22.9±15.9 | 40.36±6.10 | 34.08±23.80 | 220.6±77.5 | 256.8±91.6 | 4.30±1.60 | 61.21±15.10# |
| 其他寄生虫组 | 23.1±27.5 | 37.10±7.10 | 39.18±6.90 | 236.9±160.2 | 353.0±95.2 | 9.49±7.90 | 90.76±49.40 |
| 对照组 | 23.4±7.0 | 40.20±16.70 | 21.4±7.40 | 161.4±28.2 | 315.9±78.8* | 4.89±0.90 | 71.50±12.70# |
| P值 | 0.998 | 0.045 | 0.318 | 0.023 | 0.021 | <0.001 | 0.006 |
| 组别 | 丙氨酸氨基转移酶/（U/L） | 白蛋白/ （g/L） | 天门冬氨酸氨基转移酶/（U/L） | 乳酸脱氢酶/（U/L） | 尿酸/ （μmol/L） | 尿素/（mmol/L） | 肌酐/ （μmol/L） |
|---|---|---|---|---|---|---|---|
| 阿米巴原虫组 | 22.3±10.5 | 42.57±6.10 | 25.38±7.80 | 185.8±61.9 | 344.4±101.8* | 4.89±1.40 | 88.54±28.90 |
| 人芽囊原虫组 | 22.9±15.9 | 40.36±6.10 | 34.08±23.80 | 220.6±77.5 | 256.8±91.6 | 4.30±1.60 | 61.21±15.10# |
| 其他寄生虫组 | 23.1±27.5 | 37.10±7.10 | 39.18±6.90 | 236.9±160.2 | 353.0±95.2 | 9.49±7.90 | 90.76±49.40 |
| 对照组 | 23.4±7.0 | 40.20±16.70 | 21.4±7.40 | 161.4±28.2 | 315.9±78.8* | 4.89±0.90 | 71.50±12.70# |
| P值 | 0.998 | 0.045 | 0.318 | 0.023 | 0.021 | <0.001 | 0.006 |
| [1] | 沈继龙, 张进顺. 临床寄生虫学检验[M]. 4版. 北京: 人民卫生出版社, 2012. |
| [2] | 张小萍, 何艳燕, 王真瑜, 等. 上海市综合性医院腹泻患者中溶组织内阿米巴感染现状调查[J]. 中国血吸虫病防治杂志, 2015, 27(6):600-603. |
| [3] | 王琦, 杨改革, 杨春利, 等. 云南省腾冲市住院病人溶组织内阿米巴感染情况及影响因素分析[J]. 中国血吸虫病防治杂志, 2019, 31(2):139-142. |
| [4] | 江涛, 王加志, 俞英昉, 等. 云南省腾冲市住院患者人芽囊原虫感染情况及影响因素研究[J]. 中国人兽共患病学报, 2019, 35(10):964-969. |
| [5] | 李朝品, 王健. 淮南地区人芽囊原虫感染的流行病学调查[J]. 第四军医大学学报, 2002, 23(16):1480-1482. |
| [6] | ZULFIQAR H, MATHEW G, HORRALL S. Amebiasis[J]. Treasure Island(FL): StatPearls Publishing, 2021. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
